Interestingly, it has been proposed that these metabolic modifications not only support cancer cell survival and proliferation but also interact with oncogenic signaling pathways such as the PI3K/AKT signaling, to enhance the invasive and metastatic properties of cancer cells50. The gene discussed is AKT1; the disease is cancer.